National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

TPI 287
A synthetic, third generation taxane with potential antineoplastic activity. TPI 287 binds to tubulin and stabilizes microtubules, resulting in inhibition of microtubule assembly/disassembly dynamics, cell cycle arrest at the G2/M phase, and apoptosis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)




Previous:Torisel, tositumomab, tositumomab and iodine I 131 tositumomab, Totect, tozasertib lactate
Next:trabectedin, tranexamic acid, transdermal estrogen, transferrin receptor-targeted anti-RRM2 siRNA CALAA-01, transferrin receptor-targeted liposomal p53 cDNA

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov